...
首页> 外文期刊>American journal of applied sciences >Neuroprotective Effect of Quercetin Encapsulated Liposomes: A Novel Therapeutic Strategy against Alzheimer’s Disease | Science Publications
【24h】

Neuroprotective Effect of Quercetin Encapsulated Liposomes: A Novel Therapeutic Strategy against Alzheimer’s Disease | Science Publications

机译:槲皮素包裹的脂质体的神经保护作用:一种针对阿尔茨海默氏病的新型治疗策略科学出版物

获取原文

摘要

> Problem statement: The prevalence of Alzheimer’s disease is increasing but the efficacy of treatment is still very limited due to various factors including the blood brain barrier. Recent findings demonstrated the crucial role of oxidative stress on the pathophysiology of disease. In addition the burden of blood brain barrier can be overcome by nasal administration and vesicle-carrier mediated delivery system. Based on the potent antioxidant effect of quercetin and the burden of blood brain barrier, we hypothesized that the nasal administration of quercetin liposomes could protect against neurodegeneration in Alzheimer’s disease. Approach: This study was designed to evaluate the effect and possible action of nasal administration of quercetin liposomes on neurodegeneration in animal model of Alzheimer’s disease. Male Wistar rats were pretreated with quercetin liposomes, containing 0.5 mg of quercetin in 20 μL via intranasal route once daily continually for 2 weeks before and 1 week after AF64A administration. After the quercetin liposomes treatment, the density of neurons and cholinergic neurons in hippocampus were assessed using histochemical and immunohistochemical techniques whereas the activities of Superoxide Dismutase (SOD), Catalase (CAT), Glutathione Peroxidase (GPx) and Malondialdehide (MDA), a lipid peroxidation product, were determined using biochemical assays. Results: Quercetin liposomes attenuated the degeneration of neurons and cholinergic neurons in hippocampus. The elevation of SOD, CAT and GPx activities and the reduction of MDA in hippocampus were also observed. Therefore, the neuroprotective of quercetin liposomes occurred partly via the reduction of oxidative stress. Conclusion: Our studies suggested that nasal administration of quercetin liposomes may be the potential novel therapeutic strategy against Alzheimer’s disease. However, further researches are still essential.
机译: > 问题陈述:阿尔茨海默氏病的患病率正在上升,但由于包括血脑屏障在内的各种因素,治疗的效果仍然非常有限。最近的发现证明了氧化应激在疾病的病理生理中的关键作用。另外,通过鼻腔给药和囊泡载体介导的递送系统可以克服血脑屏障的负担。基于槲皮素的强效抗氧化作用和血脑屏障的负担,我们推测经鼻给予槲皮素脂质体可以预防阿尔茨海默氏病的神经退行性变。 方法:本研究旨在评估鼻饲槲皮素脂质体对阿尔茨海默氏病动物模型中神经退行性变的作用和可能的作用。雄性Wistar大鼠经AF64A给药前2周和给药后1周,每天一次通过鼻内途径用槲皮素脂质体预处理,该脂质体含0.5 mg槲皮素(20μL)。槲皮素脂质体处理后,使用组织化学和免疫组化技术评估海马中神经元和胆碱能神经元的密度,而脂质中的超氧化物歧化酶(SOD),过氧化氢酶(CAT),谷胱甘肽过氧化物酶(GPx)和丙二醛(MDA)的活性使用生化测定确定过氧化产物。 结果:槲皮素脂质体可减轻海马神经元和胆碱能神经元的变性。还观察到海马中SOD,CAT和GPx活性升高,MDA降低。因此,槲皮素脂质体的神经保护作用部分是通过减少氧化应激而发生的。 结论:我们的研究表明,鼻饲槲皮素脂质体可能是对抗阿尔茨海默氏病的潜在新型治疗策略。但是,进一步的研究仍然是必不可少的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号